Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

2 settembre 2021 aggiornato da: Alliance for Clinical Trials in Oncology

Randomized Phase II Study of ECF-C, IC-C, or FOLFOX-C in Metastatic Esophageal and GE Junction Cancer

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Giving more than one chemotherapy drug (combination chemotherapy) together with cetuximab may kill more tumor cells.

PURPOSE: This randomized phase II trial is studying three different combination chemotherapy regimens to compare how well they work when given together with cetuximab in treating patients with metastatic esophageal cancer or gastroesophageal junction cancer.

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to histology (squamous cell carcinoma vs adenocarcinoma) and Eastern Cooperative Oncology Group (ECOG) performance status (0 or 1 vs 2). Patients are randomized to 1 of 3 treatment arms. For more information please see the "Arms" section which includes a detailed description of the treatment regimens.

The primary objective of the study is evaluate the tumor response rate (RR) for each of the regimens in this trial and to select the most promising regimen based on RR for further testing in patients with metastatic esophageal or GE junction adenocarcinoma. The secondary objectives are:

  1. To evaluate overall survival (OS) for each of the regimens in this trial in patients with metastatic esophageal or GE junction adenocarcinoma.
  2. To evaluate progression-free survival (PFS) for each of the regimens in this trial in patients with metastatic esophageal or GE junction adenocarcinoma.
  3. To evaluate time to treatment failure (TTF) for each of the regimens in this trial in patients with metastatic esophageal or GE junction adenocarcinoma.
  4. To determine the type and severity of toxicities associated with each of these regimens in the multi-institutional phase II setting.
  5. Quantitative immunohistochemistry results will be correlated with objective response rate, overall survival and time to progression.
  6. To evaluate the cellular damage (apoptosis) as a result of oxaliplatin.
  7. To determine if germline EGFR variants correlate with skin rash in patients treated with cetuximab.
  8. To evaluate if a correlation exists between germline EGFR variants and tumor EFGR expression as measured by immunohistochemistry.

All subjects must be premedicated with diphenhydramine hydrochloride 50 mg IV (or a similar agent) prior to the first dose of cetuximab in an effort to minimize infusion and hypersensitivity reactions. Premedication is recommended prior to subsequent doses, but the dose of diphenhydramine (or similar agent) may be reduced at the investigator's discretion. More information is detailed in the protocol including a description of the premedication requirements. Patients were closely monitored for treatment-related adverse events. After completion of study treatment, patients are followed periodically for up to 2 years.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

245

Fase

  • Fase 2

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Connecticut
      • Norwalk, Connecticut, Stati Uniti, 06856
        • Norwalk Hospital
    • Delaware
      • Lewes, Delaware, Stati Uniti, 19958
        • Tunnell Cancer Center at Beebe Medical Center
      • Newark, Delaware, Stati Uniti, 19713
        • CCOP - Christiana Care Health Services
    • District of Columbia
      • Washington, District of Columbia, Stati Uniti, 20007
        • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    • Illinois
      • Aurora, Illinois, Stati Uniti, 60504
        • Rush-Copley Cancer Care Center
      • Bloomington, Illinois, Stati Uniti, 61701
        • St. Joseph Medical Center
      • Canton, Illinois, Stati Uniti, 61520
        • Graham Hospital
      • Carthage, Illinois, Stati Uniti, 62321
        • Memorial Hospital
      • Chicago, Illinois, Stati Uniti, 60637-1470
        • University of Chicago Cancer Research Center
      • Decatur, Illinois, Stati Uniti, 62526
        • Decatur Memorial Hospital Cancer Care Institute
      • Eureka, Illinois, Stati Uniti, 61530
        • Eureka Community Hospital
      • Evanston, Illinois, Stati Uniti, 60201-1781
        • Evanston Hospital
      • Galesburg, Illinois, Stati Uniti, 61401
        • Galesburg Cottage Hospital
      • Galesburg, Illinois, Stati Uniti, 61401
        • Galesburg Clinic, PC
      • Harvey, Illinois, Stati Uniti, 60426
        • Ingalls Cancer Care Center at Ingalls Memorial Hospital
      • Havana, Illinois, Stati Uniti, 62644
        • Mason District Hospital
      • Hopedale, Illinois, Stati Uniti, 61747
        • Hopedale Medical Complex
      • Joliet, Illinois, Stati Uniti, 60435
        • Joliet Oncology-Hematology Associates, Limited - West
      • Macomb, Illinois, Stati Uniti, 61455
        • Mcdonough District Hospital
      • Normal, Illinois, Stati Uniti, 61761
        • Bromenn Regional Medical Center
      • Normal, Illinois, Stati Uniti, 61761
        • Community Cancer Center
      • Ottawa, Illinois, Stati Uniti, 61350
        • Community Hospital of Ottawa
      • Ottawa, Illinois, Stati Uniti, 61350
        • Oncology Hematology Associates of Central Illinois, PC - Ottawa
      • Pekin, Illinois, Stati Uniti, 61554
        • Cancer Treatment Center at Pekin Hospital
      • Peoria, Illinois, Stati Uniti, 61636
        • Methodist Medical Center of Illinois
      • Peoria, Illinois, Stati Uniti, 61614
        • Proctor Hospital
      • Peoria, Illinois, Stati Uniti, 61637
        • OSF St. Francis Medical Center
      • Peoria, Illinois, Stati Uniti, 61615
        • CCOP - Illinois Oncology Research Association
      • Peoria, Illinois, Stati Uniti, 61615
        • Oncology Hematology Associates of Central Illinois, PC - Peoria
      • Peru, Illinois, Stati Uniti, 61354
        • Illinois Valley Community Hospital
      • Princeton, Illinois, Stati Uniti, 61356
        • Perry Memorial Hospital
      • Rockford, Illinois, Stati Uniti, 61104-2315
        • Swedish-American Regional Cancer Center
      • Spring Valley, Illinois, Stati Uniti, 61362
        • St. Margaret's Hospital
      • Springfield, Illinois, Stati Uniti, 62781-0001
        • Regional Cancer Center at Memorial Medical Center
      • Urbana, Illinois, Stati Uniti, 61801
        • Carle Cancer Center at Carle Foundation Hospital
      • Urbana, Illinois, Stati Uniti, 61801
        • CCOP - Carle Cancer Center
    • Indiana
      • Elkhart, Indiana, Stati Uniti, 46515
        • Elkhart General Hospital
      • Fort Wayne, Indiana, Stati Uniti, 46845
        • Fort Wayne Medical Oncology and Hematology
      • Indianapolis, Indiana, Stati Uniti, 46202-5289
        • Indiana University Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Stati Uniti, 46202
        • William N. Wishard Memorial Hospital
      • Kokomo, Indiana, Stati Uniti, 46904
        • Howard Community Hospital
      • La Porte, Indiana, Stati Uniti, 46350
        • Center for Cancer Therapy at LaPorte Hospital and Health Services
      • Michigan City, Indiana, Stati Uniti, 46360
        • Saint Anthony Memorial Health Centers
      • South Bend, Indiana, Stati Uniti, 46601
        • Memorial Hospital of South Bend
      • South Bend, Indiana, Stati Uniti, 46601
        • CCOP - Northern Indiana CR Consortium
      • South Bend, Indiana, Stati Uniti, 46617
        • Saint Joseph Regional Medical Center
      • South Bend, Indiana, Stati Uniti, 46617
        • South Bend Clinic
    • Iowa
      • Ames, Iowa, Stati Uniti, 50010
        • McFarland Clinic, PC
      • Bettendorf, Iowa, Stati Uniti, 52722
        • Hematology Oncology Associates of the Quad Cities
      • Cedar Rapids, Iowa, Stati Uniti, 52403
        • Cedar Rapids Oncology Associates
      • Cedar Rapids, Iowa, Stati Uniti, 52403
        • Mercy Regional Cancer Center at Mercy Medical Center
      • Des Moines, Iowa, Stati Uniti, 50309
        • CCOP - Iowa Oncology Research Association
      • Des Moines, Iowa, Stati Uniti, 50309
        • John Stoddard Cancer Center at Iowa Methodist Medical Center
      • Des Moines, Iowa, Stati Uniti, 50309
        • Medical Oncology and Hematology Associates at John Stoddard Cancer Center
      • Des Moines, Iowa, Stati Uniti, 50314
        • Medical Oncology and Hematology Associates at Mercy Cancer Center
      • Des Moines, Iowa, Stati Uniti, 50314
        • Mercy Cancer Center at Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Stati Uniti, 50316
        • John Stoddard Cancer Center at Iowa Lutheran Hospital
      • Des Moines, Iowa, Stati Uniti, 50307
        • Mercy Capitol Hospital
      • Iowa City, Iowa, Stati Uniti, 52242-1002
        • Holden Comprehensive Cancer Center at University of Iowa
      • Mason City, Iowa, Stati Uniti, 50401
        • Mercy Cancer Center at Mercy Medical Center - North Iowa
      • Ottumwa, Iowa, Stati Uniti, 52501
        • McCreery Cancer Center at Ottumwa Regional
      • Sioux City, Iowa, Stati Uniti, 51101
        • Siouxland Hematology-Oncology Associates, LLP
      • Sioux City, Iowa, Stati Uniti, 51104
        • St. Luke's Regional Medical Center
      • Sioux City, Iowa, Stati Uniti, 51104
        • Mercy Medical Center - Sioux City
      • West Des Moines, Iowa, Stati Uniti, 50266
        • Medical Oncology and Hematology Associates - West Des Moines
    • Kansas
      • Anthony, Kansas, Stati Uniti, 67003
        • Hospital District Sixth of Harper County
      • Chanute, Kansas, Stati Uniti, 66720
        • Cancer Center of Kansas, PA - Chanute
      • Dodge City, Kansas, Stati Uniti, 67801
        • Cancer Center of Kansas, PA - Dodge City
      • El Dorado, Kansas, Stati Uniti, 67042
        • Cancer Center of Kansas, PA - El Dorado
      • Fort Scott, Kansas, Stati Uniti, 66701
        • Cancer Center of Kansas - Fort Scott
      • Independence, Kansas, Stati Uniti, 67301
        • Cancer Center of Kansas-Independence
      • Kingman, Kansas, Stati Uniti, 67068
        • Cancer Center of Kansas, PA - Kingman
      • Lawrence, Kansas, Stati Uniti, 66044
        • Lawrence Memorial Hospital
      • Liberal, Kansas, Stati Uniti, 67901
        • Southwest Medical Center
      • Newton, Kansas, Stati Uniti, 67114
        • Cancer Center of Kansas, PA - Newton
      • Overland Park, Kansas, Stati Uniti, 66209
        • Menorah Medical Center
      • Parsons, Kansas, Stati Uniti, 67357
        • Cancer Center of Kansas, PA - Parsons
      • Pratt, Kansas, Stati Uniti, 67124
        • Cancer Center of Kansas, PA - Pratt
      • Salina, Kansas, Stati Uniti, 67042
        • Cancer Center of Kansas, PA - Salina
      • Shawnee Mission, Kansas, Stati Uniti, 66204
        • Shawnee Mission Medical Center
      • Wellington, Kansas, Stati Uniti, 67152
        • Cancer Center of Kansas, PA - Wellington
      • Wichita, Kansas, Stati Uniti, 67208
        • Cancer Center of Kansas, PA - Medical Arts Tower
      • Wichita, Kansas, Stati Uniti, 67214
        • Cancer Center of Kansas, PA - Wichita
      • Wichita, Kansas, Stati Uniti, 67214
        • CCOP - Wichita
      • Wichita, Kansas, Stati Uniti, 67214
        • Via Christi Cancer Center at Via Christi Regional Medical Center
      • Wichita, Kansas, Stati Uniti, 67208
        • Associates in Womens Health, PA - North Review
      • Winfield, Kansas, Stati Uniti, 67156
        • Cancer Center of Kansas, PA - Winfield
    • Maine
      • Bangor, Maine, Stati Uniti, 04401
        • CancerCare of Maine at Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, Stati Uniti, 21237
        • Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
      • Easton, Maryland, Stati Uniti, 21601
        • Shore Regional Cancer Center at Memorial Hospital - Easton
      • Elkton, Maryland, Stati Uniti, 21921
        • Union Hospital of Cecil County
    • Massachusetts
      • Boston, Massachusetts, Stati Uniti, 02114
        • Massachusetts General Hospital
      • Boston, Massachusetts, Stati Uniti, 02115
        • Dana-Farber/Brigham and Women's Cancer Center
      • Boston, Massachusetts, Stati Uniti, 02115
        • Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
      • Burlington, Massachusetts, Stati Uniti, 01805
        • Lahey Clinic Medical Center - Burlington
      • South Weymouth, Massachusetts, Stati Uniti, 02190
        • South Shore Hospital
      • Springfield, Massachusetts, Stati Uniti, 01199
        • Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    • Michigan
      • Ann Arbor, Michigan, Stati Uniti, 48106-0995
        • Saint Joseph Mercy Cancer Center
      • Ann Arbor, Michigan, Stati Uniti, 48106
        • CCOP - Michigan Cancer Research Consortium
      • Dearborn, Michigan, Stati Uniti, 48123-2500
        • Oakwood Cancer Center at Oakwood Hospital and Medical Center
      • Escanaba, Michigan, Stati Uniti, 49431
        • Green Bay Oncology, Limited - Escanaba
      • Flint, Michigan, Stati Uniti, 48503
        • Hurley Medical Center
      • Flint, Michigan, Stati Uniti, 48503
        • Genesys Hurley Cancer Institute
      • Grosse Pointe Woods, Michigan, Stati Uniti, 48236
        • Van Elslander Cancer Center at St. John Hospital and Medical Center
      • Iron Mountain, Michigan, Stati Uniti, 49801
        • Dickinson County Healthcare System
      • Jackson, Michigan, Stati Uniti, 49201
        • Foote Memorial Hospital
      • Kalamazoo, Michigan, Stati Uniti, 49007
        • Bronson Methodist Hospital
      • Kalamazoo, Michigan, Stati Uniti, 49001
        • Borgess Medical Center
      • Kalamazoo, Michigan, Stati Uniti, 49007-3731
        • West Michigan Cancer Center
      • Lansing, Michigan, Stati Uniti, 48912-1811
        • Sparrow Regional Cancer Center
      • Livonia, Michigan, Stati Uniti, 48154
        • St. Mary Mercy Hospital
      • Pontiac, Michigan, Stati Uniti, 48341-2985
        • St. Joseph Mercy Oakland
      • Port Huron, Michigan, Stati Uniti, 48060
        • Mercy Regional Cancer Center at Mercy Hospital
      • Saginaw, Michigan, Stati Uniti, 48601
        • Seton Cancer Institute at Saint Mary's - Saginaw
      • Saint Joseph, Michigan, Stati Uniti, 49085
        • Lakeland Regional Cancer Care Center - St. Joseph
      • Saint Joseph, Michigan, Stati Uniti, 49085
        • Oncology Care Associates, PLLC
      • Warren, Michigan, Stati Uniti, 48093
        • St. John Macomb Hospital
    • Minnesota
      • Burnsville, Minnesota, Stati Uniti, 55337
        • Fairview Ridges Hospital
      • Coon Rapids, Minnesota, Stati Uniti, 55433
        • Mercy and Unity Cancer Center at Mercy Hospital
      • Duluth, Minnesota, Stati Uniti, 55805
        • CCOP - Duluth
      • Duluth, Minnesota, Stati Uniti, 55805
        • Miller - Dwan Medical Center
      • Duluth, Minnesota, Stati Uniti, 55805-1983
        • Essentia Health - Duluth Clinic
      • Edina, Minnesota, Stati Uniti, 55435
        • Fairview Southdale Hospital
      • Fridley, Minnesota, Stati Uniti, 55432
        • Mercy and Unity Cancer Center at Unity Hospital
      • Hutchinson, Minnesota, Stati Uniti, 55350
        • Hutchinson Area Health Care
      • Litchfield, Minnesota, Stati Uniti, 55355
        • Meeker County Memorial Hospital
      • Maplewood, Minnesota, Stati Uniti, 55109
        • HealthEast Cancer Care at St. John's Hospital
      • Maplewood, Minnesota, Stati Uniti, 55109
        • Minnesota Oncology - Maplewood
      • Minneapolis, Minnesota, Stati Uniti, 55417
        • Veterans Affairs Medical Center - Minneapolis
      • Minneapolis, Minnesota, Stati Uniti, 55407
        • Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
      • Minneapolis, Minnesota, Stati Uniti, 55415
        • Hennepin County Medical Center - Minneapolis
      • Robbinsdale, Minnesota, Stati Uniti, 55422-2900
        • Humphrey Cancer Center at North Memorial Outpatient Center
      • Saint Louis Park, Minnesota, Stati Uniti, 55416
        • CCOP - Metro-Minnesota
      • Saint Louis Park, Minnesota, Stati Uniti, 55416
        • Park Nicollet Cancer Center
      • Saint Paul, Minnesota, Stati Uniti, 55102
        • United Hospital
      • Saint Paul, Minnesota, Stati Uniti, 55101
        • Regions Hospital Cancer Care Center
      • Shakopee, Minnesota, Stati Uniti, 55379
        • St. Francis Cancer Center at St. Francis Medical Center
      • Waconia, Minnesota, Stati Uniti, 55387
        • Ridgeview Medical Center
      • Woodbury, Minnesota, Stati Uniti, 55125
        • Minnesota Oncology - Woodbury
    • Missouri
      • Independence, Missouri, Stati Uniti, 64050
        • Independence Regional Health Center
      • Kansas City, Missouri, Stati Uniti, 64131
        • CCOP - Kansas City
      • Kansas City, Missouri, Stati Uniti, 64116
        • North Kansas City Hospital
      • Kansas City, Missouri, Stati Uniti, 64132
        • Research Medical Center
      • Kansas City, Missouri, Stati Uniti, 64108
        • Truman Medical Center - Hospital Hill
      • Kansas City, Missouri, Stati Uniti, 64111
        • Saint Luke's Cancer Institute at Saint Luke's Hospital
      • Kansas City, Missouri, Stati Uniti, 64114
        • St. Joseph Medical Center
      • Kansas City, Missouri, Stati Uniti, 64116
        • Parvin Radiation Oncology
      • Liberty, Missouri, Stati Uniti, 64068
        • Liberty Hospital
      • Saint Joseph, Missouri, Stati Uniti, 64506
        • Heartland Regional Medical Center
      • Saint Louis, Missouri, Stati Uniti, 63131
        • Missouri Baptist Cancer Center
      • Saint Louis, Missouri, Stati Uniti, 63141
        • Arch Medical Services, Incorporated at Center for Cancer Care and Research
    • Nebraska
      • Omaha, Nebraska, Stati Uniti, 68106
        • CCOP - Missouri Valley Cancer Consortium
      • Omaha, Nebraska, Stati Uniti, 68122
        • Immanuel Medical Center
      • Omaha, Nebraska, Stati Uniti, 68124
        • Alegant Health Cancer Center at Bergan Mercy Medical Center
      • Omaha, Nebraska, Stati Uniti, 68131-2197
        • Creighton University Medical Center
      • Omaha, Nebraska, Stati Uniti, 68114
        • Methodist Estabrook Cancer Center
    • Nevada
      • Las Vegas, Nevada, Stati Uniti, 89102
        • University Medical Center of Southern Nevada
      • Las Vegas, Nevada, Stati Uniti, 89106
        • CCOP - Nevada Cancer Research Foundation
    • New Hampshire
      • Lebanon, New Hampshire, Stati Uniti, 03756-0002
        • Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
    • New Jersey
      • Marlton, New Jersey, Stati Uniti, 08053
        • Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
      • Newark, New Jersey, Stati Uniti, 07112
        • Newark Beth Israel Medical Center
      • Sparta, New Jersey, Stati Uniti, 07871
        • Frederick R. and Betty M. Smith Cancer Treatment Center
      • Voorhees, New Jersey, Stati Uniti, 08043
        • Cancer Institute of New Jersey at Cooper - Voorhees
      • Voorhees, New Jersey, Stati Uniti, 08043
        • Fox Chase Virtua Health Cancer Program at Virtua West Jersey
    • New York
      • Bronx, New York, Stati Uniti, 10466
        • Our Lady of Mercy Medical Center Comprehensive Cancer Center
      • Buffalo, New York, Stati Uniti, 14215
        • Veterans Affairs Medical Center - Buffalo
      • East Syracuse, New York, Stati Uniti, 13057
        • CCOP - Hematology-Oncology Associates of Central New York
      • Glens Falls, New York, Stati Uniti, 12801
        • Charles R. Wood Cancer Center at Glens Falls Hospital
      • New York, New York, Stati Uniti, 10065
        • Memorial Sloan-Kettering Cancer Center
      • New York, New York, Stati Uniti, 10035
        • Ralph Lauren Center for Cancer Care and Prevention
    • North Carolina
      • Chapel Hill, North Carolina, Stati Uniti, 27599-7295
        • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
      • Charlotte, North Carolina, Stati Uniti, 28232-2861
        • Blumenthal Cancer Center at Carolinas Medical Center
      • Goldsboro, North Carolina, Stati Uniti, 27534
        • Wayne Memorial Hospital, Incorporated
      • Hendersonville, North Carolina, Stati Uniti, 28791
        • Pardee Memorial Hospital
      • Kinston, North Carolina, Stati Uniti, 28501
        • Kinston Medical Specialists
    • Ohio
      • Akron, Ohio, Stati Uniti, 44309-2090
        • Summa Center for Cancer Care at Akron City Hospital
      • Canton, Ohio, Stati Uniti, 44710-1799
        • Aultman Cancer Center at Aultman Hospital
      • Cleveland, Ohio, Stati Uniti, 44109
        • MetroHealth Cancer Care Center at MetroHealth Medical Center
      • Columbus, Ohio, Stati Uniti, 43210-1240
        • Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
      • Lima, Ohio, Stati Uniti, 45801
        • St. Rita's Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, Stati Uniti, 18105
        • Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
      • Bethlehem, Pennsylvania, Stati Uniti, 18015
        • St. Luke's Cancer Network at St. Luke's Hospital
      • Danville, Pennsylvania, Stati Uniti, 17822-0001
        • Geisinger Cancer Institute at Geisinger Health
      • East Stroudsburg, Pennsylvania, Stati Uniti, 18301
        • Dale and Frances Hughes Cancer Center at Pocono Medical Center
      • Hazleton, Pennsylvania, Stati Uniti, 18201
        • Geisinger Hazleton Cancer Center
      • Hershey, Pennsylvania, Stati Uniti, 17033-0850
        • Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
      • Lewistown, Pennsylvania, Stati Uniti, 17044
        • Lewistown Hospital
      • Philadelphia, Pennsylvania, Stati Uniti, 19111-2497
        • Fox Chase Cancer Center - Philadelphia
      • Philadelphia, Pennsylvania, Stati Uniti, 19104-4283
        • Abramson Cancer Center of the University of Pennsylvania
      • Philadelphia, Pennsylvania, Stati Uniti, 19107-5541
        • Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
      • Philadelphia, Pennsylvania, Stati Uniti, 19107
        • Joan Karnell Cancer Center at Pennsylvania Hospital
      • Philadelphia, Pennsylvania, Stati Uniti, 19114
        • Frankford Hospital Cancer Center - Torresdale Campus
      • Scranton, Pennsylvania, Stati Uniti, 18508
        • Hematology and Oncology Associates of Northeastern Pennsylvania
      • State College, Pennsylvania, Stati Uniti, 16803
        • Mount Nittany Medical Center
      • State College, Pennsylvania, Stati Uniti, 16801
        • Geisinger Medical Group - Scenery Park
      • Wilkes-Barre, Pennsylvania, Stati Uniti, 18711
        • Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
      • Wilkes-Barre, Pennsylvania, Stati Uniti, 18765
        • Mercy Hospital at Wilkes-Barre
      • Williamsport, Pennsylvania, Stati Uniti, 17701
        • Susquehanna Cancer Center at Divine Providence Hospital
    • South Carolina
      • Florence, South Carolina, Stati Uniti, 29501
        • McLeod Regional Medical Center
    • South Dakota
      • Sioux Falls, South Dakota, Stati Uniti, 57105
        • Avera Cancer Institute
      • Sioux Falls, South Dakota, Stati Uniti, 57105
        • Medical X-Ray Center, PC
      • Sioux Falls, South Dakota, Stati Uniti, 57117-5039
        • Sanford Cancer Center at Sanford USD Medical Center
    • Tennessee
      • Kingsport, Tennessee, Stati Uniti, 37662
        • Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    • Texas
      • Temple, Texas, Stati Uniti, 76508
        • CCOP - Scott and White Hospital
    • Vermont
      • Berlin, Vermont, Stati Uniti, 05602
        • Mountainview Medical
      • Burlington, Vermont, Stati Uniti, 05401
        • Fletcher Allen Health Care - University Health Center Campus
    • Virginia
      • Danville, Virginia, Stati Uniti, 24541
        • Danville Regional Medical Center
      • Norton, Virginia, Stati Uniti, 24273
        • Southwest Virginia Regional Cancer Center at Wellmonth Health
    • Wisconsin
      • Eau Claire, Wisconsin, Stati Uniti, 54701
        • Center for Cancer Treatment & Prevention at Sacred Heart Hospital
      • Eau Claire, Wisconsin, Stati Uniti, 54701
        • Marshfield Clinic Cancer Care at Regional Cancer Center
      • Green Bay, Wisconsin, Stati Uniti, 54307-3508
        • St. Vincent Hospital Regional Cancer Center
      • Green Bay, Wisconsin, Stati Uniti, 54301-3526
        • Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
      • Green Bay, Wisconsin, Stati Uniti, 54303
        • Green Bay Oncology, Limited at St. Mary's Hospital
      • Green Bay, Wisconsin, Stati Uniti, 54303
        • St. Mary's Hospital Medical Center - Green Bay
      • Marinette, Wisconsin, Stati Uniti, 54143
        • Bay Area Cancer Care Center at Bay Area Medical Center
      • Marshfield, Wisconsin, Stati Uniti, 54449
        • Saint Joseph's Hospital
      • Milwaukee, Wisconsin, Stati Uniti, 53215
        • Medical Consultants, Limited
      • Minocqua, Wisconsin, Stati Uniti, 54548
        • Marshfield Clinic - Lakeland Center
      • Oconto Falls, Wisconsin, Stati Uniti, 54154
        • Green Bay Oncology, Limited - Oconto Falls
      • Rhinelander, Wisconsin, Stati Uniti, 54501
        • Ministry Medical Group at Saint Mary's Hospital
      • Rice Lake, Wisconsin, Stati Uniti, 54868
        • Marshfield Clinic - Indianhead Center
      • Stevens Point, Wisconsin, Stati Uniti, 54481
        • Saint Michael's Hospital Cancer Center
      • Sturgeon Bay, Wisconsin, Stati Uniti, 54235
        • Green Bay Oncology, Limited - Sturgeon Bay
      • Wausau, Wisconsin, Stati Uniti, 54401
        • Marshfield Clinic - Wausau Center
      • Wausau, Wisconsin, Stati Uniti, 54401
        • University of Wisconcin Cancer Center at Aspirus Wausau Hospital
      • Weston, Wisconsin, Stati Uniti, 54476
        • Marshfield Clinic - Weston Center
      • Wisconsin Rapids, Wisconsin, Stati Uniti, 54494
        • Marshfield Clinic - Wisconsin Rapids Center

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

  1. Metastatic disease of the esophagus or gastroesophageal junction

    1. Histologic, cytologic or radiologic documentation of metastatic squamous cell carcinoma or adenocarcinoma of the esophagus or gastroesophageal junction. Radiologic, endoscopic, histologic or cytologic evidence of locally recurrent or locally residual (post-resection) disease is also permitted.
    2. For the purposes of this study, undifferentiated adenocarcinomas and adenosquamous tumors will be considered as adenocarcinomas. In addition, tumors involving the gastroesophageal junction will be defined by the Siewert classification.
    3. Patients with gastroesophageal junction tumors who are eligible:

      • AEG Type I: Adenocarcinoma of the distal esophagus which usually arises from an area with specialized intestinal metaplasia of the esophagus (eg, Barrett's esophagus, and may infiltrate the esophagogastric junction from above).
      • AEG Type II: True carcinoma of the cardia arising from the cardiac epithelium or short segments with intestinal metaplasia at the esophagogastric junction.
    4. Patients with gastroesophageal junction tumors who are NOT eligible:

      • AEG Type III: Subcardial gastric carcinoma which infiltrates the esophagogastric junction and distal esophagus from below.
  2. Patients must have at least one paraffin block available (or at least 15 unstained slides for analysis of tumor EGFR status.

    1. Patients with a history of esophageal and GE junction carcinoma treated by surgical resection who develop radiological or clinical evidence of metastatic cancer do not require separate histological or cytological confirmation of metastatic disease unless an interval of greater than five years has elapsed between the primary surgery and the development of metastatic disease OR the primary cancer was stage I.
    2. Clinicians should consider biopsy of lesions to establish the diagnosis of metastatic esophageal or GE junction carcinoma if there is substantial clinical ambiguity regarding the nature or source of apparent metastases.
  3. Patients with Measurable Disease - Lesions that can be accurately measured in at least one dimension (longest diameter to be recorded) as ≥ 20 mm with conventional techniques or as ≥ 10 mm with spiral CT scan.
  4. Prior Treatment:

    1. No prior chemotherapy or radiotherapy. No prior therapy which specifically and directly targets the EGF(R) pathway.
    2. No prior allergic reaction to chimerized or murine monoclonal antibody therapy or documented presence of human anti-mouse antibodies (HAMA).
    3. Patients must have completed any major surgery ≥ 4 weeks or any minor surgery ≥ 2 weeks before registration. Patients must have fully recovered from the procedure. Insertion of a vascular access device is not considered major or minor surgery.
    4. No concurrent use of investigational agents is allowed while participating in this study.
  5. Patient Characteristics:

    1. ECOG Performance Status of 0-2
    2. ≥ 18 years of age
    3. Patients must be documented to have a stable weight (or less than one pound weight loss) for at least one week prior to registration.
    4. Non-pregnant and not breast-feeding. The effects of cetuximab, cisplatin, epirubicin, fluorouracil, leucovorin, irinotecan, and oxaliplatin on a developing human fetus are not well-known. Because the risk of toxicity in nursing infants secondary to cetuximab, cisplatin, epirubicin, fluorouracil, irinotecan, and oxaliplatin treatment of the mother is unknown but may be harmful, breastfeeding must be discontinued.
  6. No myocardial infarction < 6 months prior to registration or New York Heart Association classification III or IV.
  7. No ≥ grade 2 diarrhea within 7 days prior to registration.
  8. Patients may not concurrently have any of the following conditions:

    1. Known central nervous system metastases or carcinomatous meningitis
    2. Interstitial pneumonia or symptomatic interstitial fibrosis of the lung
    3. Seizure disorder or active neurological disease requiring anti-epileptic medication
    4. ≥ grade 2 peripheral neuropathy
  9. No evidence of Gilbert's Syndrome - Patients with Gilbert's Syndrome may have a greater risk of irinotecan toxicity due to the abnormal glucuronidation of SN-38, the active metabolite of irinotecan. Evidence of Gilbert's Syndrome would include documentation of elevation of indirect bilirubin at any time in the patient's medical history.
  10. Required Initial Laboratory Data:

    1. Granulocytes ≥ 1500/µl
    2. Platelet count ≥ 100,000/µl
    3. Creatinine ≤ 1.5 mg/dL
    4. AST (SGOT) ≤ 5.0 x Upper limits of normal
    5. Total bilirubin ≤ 1.5 mg/dL
    6. Albumin ≥ 2.5 grams/dL

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Arm A (ECF + cetuximab)
Patients receive cetuximab 400 mg/m^2 IV over 120 minutes on day 1 of the first cycle, then 250 mg/m^2 IV over 60 minutes thereafter. Patients receive cetuximab IV on days 1, 8 and 15. Patients receive epirubicin 50 mg/m^2 IV after cetuximab on day 1 followed by cisplatin 60 mg/m^2 IV over 60 minutes. On days 1-21, patients receive 5-fluorouracil 200 mg/m^2/day continuous IV infusion. Treatment repeats every 21 days in the absence of disease progression and unacceptable toxicity.
dato IV
Altri nomi:
  • C225
epirubicin and 5-fluorouracil given IV
Altri nomi:
  • Ellence (epirubicin) and 5-fluorouracil (5-FU)
Sperimentale: Arm B (IC + cetuximab)
Patients receive cetuximab 400 mg/m^2 IV over 120 minutes on day 1 of the first cycle, then 250 mg/m^2 IV over 60 minutes thereafter. Patients receive cetuximab on days 1, 8 and 15. Patients receive cisplatin 30 mg/m^2 IV over 30 minutes on days 1 and 8 after cetuximab. Patients also receive irinotecan 65 mg/m^2 IV over 90 minutes on days 1 and 8 after receiving cisplatin.Treatment repeats every 21 days in the absence of disease progression and unacceptable toxicity.
dato IV
Altri nomi:
  • C225
cisplatin and irinotecan given IV
Altri nomi:
  • Platinol-AQ (cisplatin), CPT-11 (irinotecan)
Sperimentale: ARM C (FOLFOX + cetuximab)
Patients receive cetuximab 400 mg/m^2 IV over 120 minutes on day 1 of the first cycle, then 250 mg/m^2 IV over 60 minutes thereafter. Patients receive cetuximab on days 1 and 8. On Day 1, patients also receive oxaliplatin 85 mg/m^2 IV over 120 minutes and leucovorin 400 mg/m^2 IV over 120 minutes either concurrently with oxaliplatin via a separate infusion line or post oxaliplatin administration. Following leucovorin, patients will receive 5-fluorouracil 400 mg/m^2 IV bolus injection, then 5-fluorouracil 2400 mg/m^2 IV infusion over 46-48 hours. Treatment repeats every 14 days in the absence of disease progression or unacceptable toxicity.
dato IV
Altri nomi:
  • C225
oxaliplatin , leucovorin and 5-fluorouracil IV
Altri nomi:
  • Eloxatin (oxaliplatin), folinic acid (leucovorin), and 5-fluorouracil (5-FU)

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Response Rate (Complete and Partial) in Patients With Measurable Esophageal or GE Junction Adenocarcinoma
Lasso di tempo: Up to 2 years post-treatment
Response was defined using Response Evaluation Criteria In Solid Tumors (RECIST) criteria: Complete Response (CR): disappearance of all target lesions; Partial Response (PR) 30% decrease in sum of longest diameter of target lesions; Progressive Disease (PD): 20% increase in sum of longest diameter of target lesions; Stable Disease (SD): small changes that do not meet above criteria. Overall tumor response is the total number of CR and PRs in participants with adenocarcinoma who have received at least one cycle of therapy.
Up to 2 years post-treatment

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Tumor Response Rate (Complete and Partial) in Patients With Squamous Cell Carcinoma
Lasso di tempo: Up to 2 years post-treatment
Response was defined using Response Evaluation Criteria In Solid Tumors (RECIST) criteria: Complete Response (CR): disappearance of all target lesions; Partial Response (PR) 30% decrease in sum of longest diameter of target lesions; Progressive Disease (PD): 20% increase in sum of longest diameter of target lesions; Stable Disease (SD): small changes that do not meet above criteria. Overall tumor response is the total number of CR and PRs in participants with squamous cell carcinoma who have received at least one cycle of therapy.
Up to 2 years post-treatment
Overall Survival in Patients With Adenocarcinoma
Lasso di tempo: Up to 2 years post-treatment
Overall survival (OS) was defined as the time from study entry to death of any cause. The median OS with 95% CI was estimated using the Kaplan Meier method.
Up to 2 years post-treatment
Progression-free Survival in Patients With Adenocarcinoma
Lasso di tempo: Up to 2 years post-treatment
Progression free survival (PFS) was defined as the time from study entry to progression or death of any cause. The median PFS with 95% CI was estimated using the Kaplan Meier method.
Up to 2 years post-treatment
Time to Treatment Failure in Patients With Adenocarcinoma
Lasso di tempo: Up to 2 years post-treatment
Time to treatment failure (TTF) was measured from study entry until documented progression, death resulting from any cause, or end of protocol therapy because of unacceptable toxicity. The median TTF with 95% CI was estimated using the Kaplan Meier method.
Up to 2 years post-treatment

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: Peter Enzinger, MD, Dana-Farber Cancer Institute

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 settembre 2006

Completamento primario (Effettivo)

1 aprile 2011

Completamento dello studio (Effettivo)

15 ottobre 2014

Date di iscrizione allo studio

Primo inviato

26 settembre 2006

Primo inviato che soddisfa i criteri di controllo qualità

26 settembre 2006

Primo Inserito (Stima)

28 settembre 2006

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

29 settembre 2021

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 settembre 2021

Ultimo verificato

1 settembre 2021

Maggiori informazioni

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi